Whilst we uncovered some examples of chimeric transcripts starting from ERVs in AML (e.g., LTR2C-SAGE1 and LTR2B-RHEX), which are not present in differentiated myeloid cells, our analyses suggest that active A-DARs mainly harbour chromatin signatures of enhancers. This evidence concerns the gene RHEX and acute myeloid leukemia.